HER2-Positive Colorectal Carcinoma — Trials

HER2-Positive Colorectal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

6 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 3
Recruiting: 1
Ph III recruiting: 0
Growth YoY: —
Industry share: 67%
Top sponsor: Iambic Therapeutics, Inc
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06253871	A Phase 1/1b Study of IAM1363 in HER2 Cancers	recruiting	Phase 1	383	Iambic Therapeutics, IncINDUSTRY	8	Sep 9, 2026	clinicaltrials

Data updated 21 days agoSource updated Sep 9, 2026source: clinicaltrials